SCHEMBL19251504

SCHEMBL19251504

CCc1ccc(N2CCN(C)CC2)c(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.61
DRD3 P35462 5/20 0.61
HTR1A P08908 4/20 0.61
DRD4 P21917 4/20 0.61
HTR2A P28223 4/20 0.61
HTR2C P28335 4/20 0.61
KDM4E B2RXH2 2/20 0.58
MAPT P10636 1/20 0.58
RAD52 P43351 1/20 0.58
POLB P06746 1/20 0.50
SIGMAR1 Q99720 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
TMEM97 Q5BJF2 1/20 0.49
HTR6 P50406 1/20 0.46
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 2/20 0.44
TSHR P16473 1/20 0.44
CASP1 P29466 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485868 0.85 MAPT (0.61) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24478309 0.83 DRD2 (0.55) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL14554255 0.83 HTR1A (0.47) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL14228541 0.83 HTR1A (0.51) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL4492340 0.83 MAPT (0.60) MAPTSIGMAR1CYP2D6NPC1RAB9A
SCHEMBL8427926 0.81 ALDH1A1 (0.49) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL12142119 0.81 DRD2 (0.62) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL17543217 0.80 ALDH1A3 (0.42) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL23544876 0.80 MAPT (0.54) KDM4EMAPTPOLBCYP2D6ALDH1A1
SCHEMBL17642835 0.79 DRD2 (0.57) DRD2DRD3HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46511-E1 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity HANMI SCIENCE CO., LTD. (KR) 2017-08-15 US disclosed